News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Applied NeuroSolutions, Inc. (APNS.OB)’s Q3 2008 Alzheimer’s Disease Serum Diagnostic Development Program Update



11/19/2008 8:31:31 AM

VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.AppliedNeuroSolutions.com), a Company focused on the development of an integrated product portfolio for the treatment and diagnosis of Alzheimer’s disease (“AD”), recently announced its financial results for the quarter ended September 30, 2008 and today provides an update on its serum diagnostic development program.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES